Literature DB >> 12906880

Sense and antisense transcripts in the histone H1 (HIS-1) locus of Leishmania major.

Sabina I Belli1, Séverine Monnerat, Cédric Schaff, Slavica Masina, Tanja Noll, Peter J Myler, Kenneth Stuart, Nicolas Fasel.   

Abstract

Histone H1 in the parasitic protozoan Leishmania is a developmentally regulated protein encoded by two genes, HIS-1.1 and HIS-1.2. These genes are separated by approximately 20 kb of sequence and are located on the same DNA strand of chromosome 27. When Northern blots of parasite RNA were probed with HIS-1 strand-specific riboprobes, we detected sense and antisense transcripts that were polyadenylated and developmentally regulated. When the HIS-1.2 coding region was replaced with the coding region of the neomycin phosphotransferase gene, antisense transcription of this gene was unaffected, indicating that the regulatory elements controlling antisense transcription were located outside of the HIS-1.2 gene, and that transcription in Leishmania can occur from both DNA strands even in the presence of transcription of a selectable marker in the complementary strand. A search for other antisense transcripts within the HIS-1 locus identified an additional transcript (SC-1) within the intervening HIS-1 sequence, downstream of adenine and thymine-rich sequences. These results show that gene expression in Leishmania is not only regulated polycistronically from the sense strand of genomic DNA, but that the complementary strand of DNA also contains sequences that could drive expression of open reading frames from the antisense strand of DNA. These findings suggest that the parasite has evolved in such a way as to maximise the transcription of its genome, a mechanism that might be important for it to maintain virulence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906880     DOI: 10.1016/s0020-7519(03)00126-7

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  7 in total

1.  Glucosylated hydroxymethyluracil, DNA base J, prevents transcriptional readthrough in Leishmania.

Authors:  Henri G A M van Luenen; Carol Farris; Sabrina Jan; Paul-Andre Genest; Pankaj Tripathi; Arno Velds; Ron M Kerkhoven; Marja Nieuwland; Andrew Haydock; Gowthaman Ramasamy; Saara Vainio; Tatjana Heidebrecht; Anastassis Perrakis; Ludo Pagie; Bas van Steensel; Peter J Myler; Piet Borst
Journal:  Cell       Date:  2012-08-31       Impact factor: 41.582

2.  A novel class of developmentally regulated noncoding RNAs in Leishmania.

Authors:  Carole Dumas; Conan Chow; Michaela Müller; Barbara Papadopoulou
Journal:  Eukaryot Cell       Date:  2006-10-27

3.  Retention and loss of RNA interference pathways in trypanosomatid protozoans.

Authors:  Lon-Fye Lye; Katherine Owens; Huafang Shi; Silvane M F Murta; Ana Carolina Vieira; Salvatore J Turco; Christian Tschudi; Elisabetta Ullu; Stephen M Beverley
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

4.  Apoptosis-like programmed cell death induces antisense ribosomal RNA (rRNA) fragmentation and rRNA degradation in Leishmania.

Authors:  P K Padmanabhan; M Samant; S Cloutier; M J Simard; B Papadopoulou
Journal:  Cell Death Differ       Date:  2012-07-06       Impact factor: 15.828

5.  Rapid decay of unstable Leishmania mRNAs bearing a conserved retroposon signature 3'-UTR motif is initiated by a site-specific endonucleolytic cleavage without prior deadenylation.

Authors:  Michaela Müller; Prasad K Padmanabhan; Annie Rochette; Debdutta Mukherjee; Martin Smith; Carole Dumas; Barbara Papadopoulou
Journal:  Nucleic Acids Res       Date:  2010-05-07       Impact factor: 16.971

6.  Methodology optimizing SAGE library tag-to-gene mapping: application to Leishmania.

Authors:  Sondos Smandi; Fatma Z Guerfali; Mohamed Farhat; Khadija Ben-Aissa; Dhafer Laouini; Lamia Guizani-Tabbane; Koussay Dellagi; Alia Benkahla
Journal:  BMC Res Notes       Date:  2012-01-27

7.  Naturally occurring antisense RNA of histone H2a in mouse cultured cell lines.

Authors:  Hiromi Nishida; Yasuhiro Tomaru; Yuko Oho; Yoshihide Hayashizaki
Journal:  BMC Genet       Date:  2005-05-14       Impact factor: 2.797

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.